You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Ranibizumab for treating diabetic macular oedema

  • Technology appraisal guidance
  • Reference number: TA274
  • Published:  27 February 2013
  • Last updated:  26 October 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015

TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015 TA274 Macular oedema (diabetic) - ranibizumab: appendix A - GE decision paper - March 2015
10 April 2015
(67.61 Kb 19 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 07 April 2015

Back to top